When the companies first unveiled their takeover plans ... of 2023 that life sciences conglomerate Danaher had expressed an interest in purchasing Catalent at a “significant premium,” sending ...
Danaher Corporation DHR is scheduled to release first-quarter 2024 results on Apr 23, before market open. The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing ...
Danaher Corporation DHR is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence. Image ...
CRANBROOK, Mich. – Jeanne Zoli Danaher was born Aug, 19, 1934, the second child of Theodore and Emma Zoli of Torrington, Conn. Throughout her life, Jeanne was proud of her Italian heritage and ...
As of April 17, 2024, the average one-year price target for Danaher is 269.54. The forecasts range from a low of 217.15 to a high of $304.50. The average price target represents an increase of 12. ...
Danaher DHR has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ...
Danaher (NYSE:DHR) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...
Deep-pocketed investors have adopted a bearish approach towards Danaher DHR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...